UY36922A - ASGR INHIBITORS - Google Patents
ASGR INHIBITORSInfo
- Publication number
- UY36922A UY36922A UY0001036922A UY36922A UY36922A UY 36922 A UY36922 A UY 36922A UY 0001036922 A UY0001036922 A UY 0001036922A UY 36922 A UY36922 A UY 36922A UY 36922 A UY36922 A UY 36922A
- Authority
- UY
- Uruguay
- Prior art keywords
- asgr
- methods
- binding proteins
- inhibitors
- administering
- Prior art date
Links
Abstract
Se describen proteínas de unión al antígeno que interactúan con ASGR, ASGR-1 y/o ASGR-2, así como métodos para producir y utilizar dichas proteínas de unión al antígeno. Métodos para tratar y prevenir la enfermedad cardiovascular mediante la administración de una cantidad farmacéuticamente eficaz de proteínas de unión al antígeno de ASGR, ASGR-1 y/o ASGR-2. Se describen métodos para tratar y prevenir la enfermedad cardiovascular mediante la administración de una cantidad farmacéuticamente eficaz de composiciones de ARN interferente que reducen la expresión de ASGR, ASGR-1 y/o ASGR-2.Antigen binding proteins that interact with ASGR, ASGR-1 and / or ASGR-2 are described, as well as methods for producing and using said antigen binding proteins. Methods for treating and preventing cardiovascular disease by administering a pharmaceutically effective amount of antigen-binding proteins of ASGR, ASGR-1 and / or ASGR-2. Methods for treating and preventing cardiovascular disease are described by administering a pharmaceutically effective amount of interfering RNA compositions that reduce the expression of ASGR, ASGR-1 and / or ASGR-2.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562234546P | 2015-09-29 | 2015-09-29 | |
US201562259533P | 2015-11-24 | 2015-11-24 | |
US201662319740P | 2016-04-07 | 2016-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36922A true UY36922A (en) | 2017-03-31 |
Family
ID=58689632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036922A UY36922A (en) | 2015-09-29 | 2016-09-28 | ASGR INHIBITORS |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW201726726A (en) |
UY (1) | UY36922A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116948030A (en) * | 2022-04-25 | 2023-10-27 | 武汉大学 | anti-ASGR 1 monoclonal antibody and application thereof |
-
2016
- 2016-09-28 UY UY0001036922A patent/UY36922A/en not_active Application Discontinuation
- 2016-09-29 TW TW105131432A patent/TW201726726A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201726726A (en) | 2017-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890285A1 (en) | ANTIBODIES AGAINST PD-1, ACTIVATED ANTIBODIES AGAINST PD-1 AND METHODS OF THEIR APPLICATION | |
CO2018000104A2 (en) | Antibody molecules that bind to cd22 | |
CL2018000429A1 (en) | Kras expression modulators | |
EA201990293A1 (en) | MULTI-SPECIFIC ANTIBODIES AGAINST CD40 AND CD137 | |
EA201891983A1 (en) | COMBINED THERAPY WITH ANTIBODIES TO CD73 | |
EA201792414A1 (en) | ANTIBODIES AGAINST CD166, ACTIVATED ANTIBODIES AGAINST CD166 AND METHODS OF THEIR APPLICATION | |
CU24498B1 (en) | FACTOR XI ANTIBODIES | |
CO2018000211A2 (en) | Antibody molecules that bind to CD45 | |
MX2022011002A (en) | Humanized or chimeric cd3 antibodies. | |
EA201792413A1 (en) | ANTIBODIES AGAINST CD71, ACTIVATED ANTIBODIES AGAINST CD71 AND METHODS OF THEIR APPLICATION | |
EA201890630A1 (en) | ANTIBODIES AGAINST PD-1 AND METHODS OF THEIR APPLICATION | |
BR112017001579A2 (en) | anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable cd3 antibodies and methods of use | |
EP4249515A3 (en) | Humanized or chimeric cd3 antibodies | |
MX2018008934A (en) | Anti-ror1 antibodies, ror1 x cd3 bispecific antibodies, and methods of using the same. | |
EA201891339A1 (en) | AQUEOUS PHARMACEUTICAL PREPARATION THAT CONTAINS ANTIBODY TO PD-L1 AVELUMAB | |
MX2016012124A (en) | Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof. | |
CO2018000410A2 (en) | Antibody molecules that bind to cd79 | |
WO2018151821A8 (en) | Antibodies to alpha-synuclein and uses thereof | |
WO2016044189A8 (en) | Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists | |
PH12014501122A1 (en) | Methods of treatment using an antibody against interferon gamma | |
EA201690881A1 (en) | COMPOUNDS INHIBITORS AUTOTAXIN | |
MX2018015272A (en) | Anti-cd98 antibodies and antibody drug conjugates. | |
BR112015030356A2 (en) | methods of treatment of a taupathy | |
EA201692204A1 (en) | COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR | |
EA201890747A1 (en) | METHODS OF TREATING INFLAMMATORY DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20221129 |